Cargando…

Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sjögren’s syndrome and rheumatoid arthritis

INTRODUCTION: Faecal calprotectin (FC) has been proposed to be a biomarker of gastrointestinal (GI) disease in systemic sclerosis (SSc). The purpose of this study was to extend cross-sectional observations and prospectively assess the variability of FC over time in SSc patients. We also aimed to exa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andréasson, Kristofer, Saxne, Tore, Scheja, Agneta, Bartosik, Izabela, Mandl, Thomas, Hesselstrand, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978565/ https://www.ncbi.nlm.nih.gov/pubmed/24499541 http://dx.doi.org/10.1186/ar4475

Ejemplares similares

Elevated levels of faecal calprotectin in primary Sjögren’s syndrome is common and associated with concomitant organic gastrointestinal disease
por: Andréasson, Kristofer, et al.
Publicado: (2016)

Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment
por: Nived, Per, et al.
Publicado: (2018)

Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis
por: Hamberg, Viggo, et al.
Publicado: (2022)

Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis
por: Okrój, Marcin, et al.
Publicado: (2016)

Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjögren’s syndrome and systemic sclerosis
por: Andraos, Rama, et al.
Publicado: (2022)

Severe intestinal dysbiosis is prevalent in primary Sjögren’s syndrome and is associated with systemic disease activity
por: Mandl, Thomas, et al.
Publicado: (2017)

Cartilage oligomeric matrix protein-induced complement activation in systemic sclerosis
por: Otteby, Kaisa E, et al.
Publicado: (2013)

The Role of Calprotectin in Rheumatoid Arthritis
por: Wang, Qin, et al.
Publicado: (2019)

High frequency ultrasound of skin involvement in systemic sclerosis – a follow-up study
por: Hesselstrand, Roger, et al.
Publicado: (2015)

Faecal calprotectin concentration in children with coeliac disease
por: Szaflarska-Popławska, Anna, et al.
Publicado: (2020)

Guidance on the interpretation of faecal calprotectin levels in children
por: Orfei, Martina, et al.
Publicado: (2021)

Pulmonary arterial hypertension in systemic sclerosis—when criteria and pathobiology differ
por: Andréasson, Kristofer, et al.
Publicado: (2019)

Multiple Manifestations of Systemic Sclerosis Affect Walk Distance
por: Andréasson, Kristofer, et al.
Publicado: (2021)

Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease
por: Lamb, C A, et al.
Publicado: (2011)

Faecal calprotectin indicates intestinal inflammation in COVID-19
por: Effenberger, Maria, et al.
Publicado: (2020)

Gastrointestinal manifestations and their relation to faecal calprotectin in children with autism
por: Azouz, Hanan Galal, et al.
Publicado: (2021)

Faecal calprotectin in COVID-19 patients with intestinal symptoms
por: Ellakany, Walid Ismail, et al.
Publicado: (2022)

Diagnostic accuracy of faecal calprotectin in patients with active perianal fistulas
por: Stevens, Toer W, et al.
Publicado: (2019)

Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation—a prospective, observational study
por: Andréasson, Kristofer, et al.
Publicado: (2020)

Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms
por: Mowat, Craig, et al.
Publicado: (2016)

Comparison of a rapid test and an automated method for faecal calprotectin measurement
por: Martins, Sandra, et al.
Publicado: (2019)

Predictive value of faecal calprotectin in ulcerative colitis – single centre experience
por: Grgić, Dora, et al.
Publicado: (2022)

Cardiovascular disease risk in early rheumatoid arthritis: the impact of cartilage oligomeric matrix protein (COMP) and disease activity
por: Rydell, Emil, et al.
Publicado: (2023)

Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication
por: Andréasson, Kristofer, et al.
Publicado: (2019)

Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
por: Crnkic Kapetanovic, Meliha, et al.
Publicado: (2013)

Disease activity level, remission and response in established rheumatoid arthritis: Performance of various criteria sets in an observational cohort, treated with anti-TNF agents
por: Gülfe, Anders, et al.
Publicado: (2009)

Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats
por: Vingsbo-Lundberg, Carina, et al.
Publicado: (1998)

The association between faecal host DNA or faecal calprotectin and feed efficiency in pigs fed yeast-enriched protein concentrate
por: Slinger, K. R., et al.
Publicado: (2019)

Respiratory symptoms are poor predictors of concomitant chronic obstructive pulmonary disease in patients with primary Sjögren’s syndrome
por: Strevens Bolmgren, Victor, et al.
Publicado: (2017)

Usefulness of Faecal Calprotectin Measurement in Children with Various Types of Inflammatory Bowel Disease
por: Komraus, Marzena, et al.
Publicado: (2012)

Effect of age, gestation and lactation on faecal IgA and calprotectin concentrations in dogs
por: Grellet, Aurélien, et al.
Publicado: (2014)

Faecal calprotectin and gut microbiota do not predict enteropathy in very preterm infants
por: Campeotto, Florence, et al.
Publicado: (2020)

New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method
por: Castiglione, Vincent, et al.
Publicado: (2022)

Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept
por: Crnkic, Meliha, et al.
Publicado: (2003)

Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
por: Jarlborg, Matthias, et al.
Publicado: (2020)

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
por: van Rheenen, Patrick F, et al.
Publicado: (2010)

Faecal calprotectin and magnetic resonance imaging in detecting Crohn’s disease endoscopic postoperative recurrence
por: Baillet, Pierre, et al.
Publicado: (2018)

Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting
por: Noebauer, Britta, et al.
Publicado: (2017)

Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease
por: Zhang, Wei, et al.
Publicado: (2019)

Faecal Calprotectin and 7-α Cholestenone Levels in Microscopic Colitis: Experience from Edinburgh
por: Davie, Matt, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fv4o6lvmd8j5ddu7hbg4458a5m